1. Short title This Act may be cited as the Interdiction of Fentanyl in Postal Mail at Federal Prisons Act . 2. Findings Congress finds the following: (1) The Bureau of Prisons has 122 institutions located throughout the United States, employs nearly 38,000 employees, and is responsible for more than 150,000 Federal inmates. (2) Inmate mail is a primary entry point for smuggling drugs into correctional facilities, with tainted mail incidents also on the rise. (3) Elimination of dangerous contraband, including synthetic drugs, in mail is essential to protecting the health and safety of employees of the Bureau of Prisons and Federal inmates. (4) Prisons in the United States are increasingly deadly facilities, with a 600 percent rise in drug overdoses in recent years. (5) The introduction of synthetic drugs, particularly fentanyl and fentanyl analogues, into correctional facilities by mail threatens employees, inmates, and the security of correctional institutions, and the practice of deliberately lacing opioids to ensure targeted lethality represents a dramatic emerging concern. (6) The foregoing factors add tremendous pressures and workload that further burden existing employees, commonly reassigning officers from other functions to assist in processing mail. (7) Employees at correctional facilities at Federal, State, and local levels continue to request drug interdiction technologies to protect themselves and inmates. (8) A congressionally authorized digital mail scanning pilot program at the Federal Correctional Institution, Beckley, West Virginia, and the United States Penitentiary, Canaan, Pennsylvania, from March 2020 through June 2021, demonstrated effective interdiction technology and practices aimed at eliminating dangerous contraband arriving through the mail and served as an effective deterrent to smuggling attempts. (9) Apart from digital mail scanning, there is no widely deployed interdiction technology that has demonstrated a 100 percent efficacy to detecting fentanyl, and other synthetic drugs,